HealthDay - TUESDAY, June 29 (HealthDay News) -- Antiviral therapy may halt or slow recurrence of liver cancer in patients with chronic hepatitis B and extend their lives, finds a new study.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.